Hanna Usenko

Statistics

Publications

Citations

H-Index

Active since

2022

Affiliations

Hanna Usenko is an author at Dana-Farber Cancer Institute specializing in rituximab-based therapy, relapsed chronic lymphocytic leukemia, and primary refractory lymphoma.

Publications per year

2022–2022

Publications

Lisaftoclax (APG-2575) Safety and Activity As Monotherapy or Combined with Acalabrutinib or Rituximab in Patients (pts) with Treatment-Naïve, Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (R/R CLL/SLL): Initial Data from a Phase 2 Global Study

Matthew S. Davids, Asher Chanan‐Khan, Boyd Mudenda et al. · Blood · 2022 · 16 citations

Pharmacy, Pharmacology, Pharmacotherapy +16

1–1 of 1